| Ytd | 33.14% | |
| 1y | 108.04% |
| Open | 4.45 | Prev Close | 4.49 | Low | 4.45 | High | 4.77 | Mkt Cap | 196.23M |
| Vol | 78.30K | Avg Vol | 179.54K | EPS | -0.22 | P/E | N/A | Forward P/E | -3.39 |
| Beta | 1.21 | Short Ratio | 5.49 | Inst. Own | 40.43% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 4.01 | 200-d Avg | 3.64 | 1yr Est | 2.83 |
APYX News
https://www.sec.gov/ix?doc=/Archives/edgar/data/719135/000149315226029081/form8-k.htm
In this study, 22 patients received a single treatment session combining these modalities to address
The study evaluated patient-reported outcomes following liposuction with and without helium plasma r
Apyx Medical (NASDAQ:APYX) raises FY2026 sales outlook from $57.500 million-$58.500 million to $59.0
Apyx Medical (NASDAQ:APYX) reported quarterly losses of $(0.05) per share which beat the analyst con
Craig-Hallum analyst Matthew Hewitt maintains Apyx Medical (NASDAQ:APYX) with a Buy and raises th
Wall Street analysts upgraded Uniqure NV, Apyx Medical Inc, J M Smucker Co, and VTEX with raised pri
Apyx Medical (NASDAQ:APYX) sees FY2026 sales of $57.500 million-$58.500 million vs $55.480 million a
Apyx Medical (NASDAQ:APYX) reported quarterly losses of $(0.03) per share which beat the analyst con
Roth Capital analyst Kyle Bauser initiates coverage on Apyx Medical (NASDAQ:APYX) with a Buy rati
Apyx Medical Corporation (NASDAQ:APYX) (the "Company" or "Apyx Medical") the leader
Apyx Medical Corporation (NASDAQ:APYX) (the "Company" or "Apyx Medical") the leader
Citizens analyst David Turkaly upgrades Apyx Medical (NASDAQ:APYX) from Market Perform to Market
Apyx Medical (NASDAQ:APYX) raises FY2025 sales outlook from $50.000 million-$52.000 million to $50.5
Apyx Medical (NASDAQ:APYX) reported quarterly losses of $(0.05) per share which beat the analyst con
Initiated Nationwide Commercial Launch of AYON in SeptemberThe Company is Hosting a Virtual Key Opin
Strong clinical interest and early procedures completedEntered into distribution agreement with Glam
Apyx Medical (NASDAQ:APYX) affirms FY2025 sales outlook from $47.60 million-$49.00 million to $47.60
Apyx Medical (NASDAQ:APYX) reported quarterly losses of $(0.10) per share which beat the analyst con
Apyx Medical (NASDAQ:APYX) reported quarterly losses of $(0.12) per share which beat the analyst con
Apyx Medical Corporation (NASDAQ:APYX) (the "Company"), the manufacturer of a proprietary he
Apyx® Medical Corporation (NASDAQ:APYX) ("Apyx Medical"; the "Company"), the manufac
The Company is introducing revenue guidance for the year ending December 31, 2025:Total revenue in t
The Company is updating its financial guidance for the year ending December 31, 2024 to:Total revenu
The annualized future cost savings from the reduction in force is estimated to be approximately $4.3
Apyx Medical (NASDAQ:APYX) reported quarterly losses of $(0.14) per share which beat the analyst con
Demonstrates a statistically significant reduction in adverse events associated with the use of Renu
Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is expected to report quarte
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnin
Gainers Amyris, Inc. (NASDAQ: AMRS) shares jumped 179.1% to $0.1839. Amyris shares dipped over 8
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterl
Gainers Addentax Group Corp. (NASDAQ: ATXG) shares jumped 47.3% to $9.68. Addentax Group is launc
Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings
Companies Reporting Before The Bell • KVH Industries (NASDAQ:KVHI) is projected to report quarterly
On Friday, 64 companies achieved new lows for the year.